Cardiff Oncology Stock Forecast - Accumulation Distribution

CRDF Stock  USD 2.84  0.18  6.77%   
Cardiff Stock Forecast is based on your current time horizon. We recommend always using this module together with an analysis of Cardiff Oncology's historical fundamentals, such as revenue growth or operating cash flow patterns.
As of 6th of January 2026, the RSI of Cardiff Oncology's share price is approaching 48 suggesting that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Cardiff Oncology, making its price go up or down.

Momentum 48

 Impartial

 
Oversold
 
Overbought
The successful prediction of Cardiff Oncology's future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Cardiff Oncology and does not consider all of the tangible or intangible factors available from Cardiff Oncology's fundamental data. We analyze noise-free headlines and recent hype associated with Cardiff Oncology, which may create opportunities for some arbitrage if properly timed. Below are the key fundamental drivers impacting Cardiff Oncology's stock price prediction:
EPS Estimate Next Quarter
(0.22)
EPS Estimate Current Year
(0.78)
EPS Estimate Next Year
(0.76)
Wall Street Target Price
9.75
EPS Estimate Current Quarter
(0.21)
Using Cardiff Oncology hype-based prediction, you can estimate the value of Cardiff Oncology from the perspective of Cardiff Oncology response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Cardiff Oncology using Cardiff Oncology's stock options and short interest. It helps to benchmark the overall future attitude of investors towards Cardiff using crowd psychology based on the activity and movement of Cardiff Oncology's stock price.

Cardiff Oncology Short Interest

A significant increase or decrease in Cardiff Oncology's short interest from the previous month could be a good indicator of investor sentiment towards Cardiff. Short interest can provide insight into the potential direction of Cardiff Oncology stock and how bullish or bearish investors feel about the market overall.
200 Day MA
2.7481
Short Percent
0.2459
Short Ratio
17.3
Shares Short Prior Month
15.6 M
50 Day MA
2.352

Cardiff Oncology Hype to Price Pattern

Investor biases related to Cardiff Oncology's public news can be used to forecast risks associated with an investment in Cardiff. The trend in average sentiment can be used to explain how an investor holding Cardiff can time the market purely based on public headlines and social activities around Cardiff Oncology. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Cardiff Oncology's market sentiment to its price can help taders to make decisions based on the overall investors consensus about Cardiff Oncology.

Cardiff Oncology Implied Volatility

    
  2.26  
Cardiff Oncology's implied volatility exposes the market's sentiment of Cardiff Oncology stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Cardiff Oncology's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Cardiff Oncology stock will not fluctuate a lot when Cardiff Oncology's options are near their expiration.

Cardiff Oncology after-hype prediction price

    
  USD 3.28  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Cardiff Oncology to cross-verify your projections.
For more detail on how to invest in Cardiff Stock please use our How to Invest in Cardiff Oncology guide.The current Inventory Turnover is estimated to decrease to -0.03. The current Payables Turnover is estimated to decrease to 0.09. The Cardiff Oncology's current Common Stock Shares Outstanding is estimated to increase to about 57.5 M, while Net Loss is projected to decrease to (36.6 M).

Open Interest Against 2026-02-20 Cardiff Option Contracts

Although open interest is a measure utilized in the options markets, it could be used to forecast Cardiff Oncology's spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Cardiff Oncology's options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Cardiff Oncology stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Cardiff Oncology's open interest, investors have to compare it to Cardiff Oncology's spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Cardiff Oncology is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Cardiff. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.

Cardiff Oncology Additional Predictive Modules

Most predictive techniques to examine Cardiff price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Cardiff using various technical indicators. When you analyze Cardiff charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
Cardiff Oncology has current Accumulation Distribution of 85045.55. The accumulation distribution (A/D) indicator shows the degree to which Cardiff Oncology is accumulated by the market over a given period. It uses the quote sensitivity to the highest or lowest daily price of Cardiff Oncology to determine if accumulation or reduction is taking place in the market. This value is adjusted by Cardiff Oncology trading volume to give more weight to distributions with higher volume over lower volume.
Check Cardiff Oncology VolatilityBacktest Cardiff OncologyInformation Ratio  

Cardiff Oncology Trading Date Momentum

On January 05 2026 Cardiff Oncology was traded for  2.84  at the closing time. The top price for the day was 2.90  and the lowest listed price was  2.64 . The trading volume for the day was 948.6 K. The trading history from January 5, 2026 did not affect price variability. The overall trading delta against the current closing price is 5.28% .
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
Compare Cardiff Oncology to competition

Other Forecasting Options for Cardiff Oncology

For every potential investor in Cardiff, whether a beginner or expert, Cardiff Oncology's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Cardiff Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Cardiff. Basic forecasting techniques help filter out the noise by identifying Cardiff Oncology's price trends.

Cardiff Oncology Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Cardiff Oncology stock to make a market-neutral strategy. Peer analysis of Cardiff Oncology could also be used in its relative valuation, which is a method of valuing Cardiff Oncology by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Cardiff Oncology Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Cardiff Oncology's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Cardiff Oncology's current price.

Cardiff Oncology Market Strength Events

Market strength indicators help investors to evaluate how Cardiff Oncology stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Cardiff Oncology shares will generate the highest return on investment. By undertsting and applying Cardiff Oncology stock market strength indicators, traders can identify Cardiff Oncology entry and exit signals to maximize returns.

Cardiff Oncology Risk Indicators

The analysis of Cardiff Oncology's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Cardiff Oncology's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting cardiff stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Currently Active Assets on Macroaxis

When determining whether Cardiff Oncology is a strong investment it is important to analyze Cardiff Oncology's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Cardiff Oncology's future performance. For an informed investment choice regarding Cardiff Stock, refer to the following important reports:
Check out Historical Fundamental Analysis of Cardiff Oncology to cross-verify your projections.
For more detail on how to invest in Cardiff Stock please use our How to Invest in Cardiff Oncology guide.
You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cardiff Oncology. If investors know Cardiff will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cardiff Oncology listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.79)
Revenue Per Share
0.008
Quarterly Revenue Growth
(0.27)
Return On Assets
(0.53)
Return On Equity
(1.03)
The market value of Cardiff Oncology is measured differently than its book value, which is the value of Cardiff that is recorded on the company's balance sheet. Investors also form their own opinion of Cardiff Oncology's value that differs from its market value or its book value, called intrinsic value, which is Cardiff Oncology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cardiff Oncology's market value can be influenced by many factors that don't directly affect Cardiff Oncology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cardiff Oncology's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cardiff Oncology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cardiff Oncology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.